FDA recall D-0666-2024 · initiated Jun 26, 2024
May cause temporary or medically reversible harm; low probability of serious harm.
Marketed without an approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac, and phenylbutazone.